These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35116636)

  • 1. Expression level of epithelial cell adhesion molecule (EpCAM) of circulating tumor cells (CTCs) of patients with NSCLC as an early indicator to monitor the effects of postoperative adjuvant chemotherapy.
    Zhen Z; Li YS; Su CY; Cheng X; Zhou SJ; Han Y; Yu DP; Song XY; Xiao N; Liu ZD; Wang F
    Transl Cancer Res; 2021 Jul; 10(7):3299-3305. PubMed ID: 35116636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of circulating tumor cells in peripheral blood of patients with non-small cell lung cancer and its detection.
    Bu XM; Xu FF; Ma J; Jiang B
    J Biol Regul Homeost Agents; 2018; 32(4):843-849. PubMed ID: 30043565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine inhibits the micrometastasis of non-small cell lung cancer by targeting the EpCAM-positive circulating tumor cells via the HGF/cMET pathway.
    Liao ZJ; Guo YH; Zhao Z; Yao JT; Xu R; Nan KJ
    Int J Oncol; 2014 Aug; 45(2):651-8. PubMed ID: 24867356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical value of classified detection of circulating tumor cells in peripheral blood of NSCLC patients].
    Yin HL; Yin J; Chen LW; Li N; Liu ZA; Hu ZB; Shen HB
    Zhonghua Zhong Liu Za Zhi; 2016 Sep; 38(9):677-81. PubMed ID: 27647400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application.
    Yin J; Wang Y; Yin H; Chen W; Jin G; Ma H; Dai J; Chen J; Jiang Y; Wang H; Liu Z; Hu Z; Shen H
    PLoS One; 2015; 10(8):e0137076. PubMed ID: 26317979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Cancer Stem Cells Expressing EpCAM/CD90 in Hepatocellular Carcinoma: A Pilot Study for Predicting Tumor Recurrence after Living Donor Liver Transplantation.
    Hwang HS; Yoo JE; Han DH; Choi JS; Lee JG; Joo DJ; Kim MS; Kim SI; Choi GH; Park YN
    Gut Liver; 2022 May; 16(3):443-455. PubMed ID: 34737243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Plasticity of Circulating Tumor Cells in Ovarian Cancer During Platinum-containing Chemotherapy.
    Gening SO; Dolgova DR; Abakumova TV; Antoneeva II; Gening TP
    Curr Cancer Drug Targets; 2021; 21(11):965-974. PubMed ID: 34288839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of EpCAM/MUC1 mRNA-positive cells in non-small cell lung cancer patients.
    Zhu WF; Li J; Yu LC; Wu Y; Tang XP; Hu YM; Chen YC
    Tumour Biol; 2014 Feb; 35(2):1211-9. PubMed ID: 24061641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and prognostic significance of detecting
    Rehulkova A; Chudacek J; Prokopova A; Vidlarova M; Stranska J; Drabek J; Potockova J; Trojanec R; Vrbkova J; Skarda J; Bohanes T; Szkorupa M; Tolmaci B; Klein J; Srovnal J; Hajduch M
    Transl Lung Cancer Res; 2023 May; 12(5):1034-1050. PubMed ID: 37323172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.
    Zhou Y; Wang B; Wu J; Zhang C; Zhou Y; Yang X; Zhou J; Guo W; Fan J
    BMC Cancer; 2016 Jul; 16():506. PubMed ID: 27439521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
    Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
    Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
    Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
    PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Rare Case of Extremely High Counts of EpCAM
    Jiang TT; Li HP; Li YC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):711-715. PubMed ID: 35871746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What information could the main actors of liquid biopsy provide? -a representative case of non-small cell lung cancer (NSCLC).
    Pezzuto A; Manicone M; Scaini MC; Ricci A; Mariotta S; Zamarchi R; Rossi E
    J Thorac Dis; 2018 Jul; 10(7):E570-E576. PubMed ID: 30174936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of EpCAM and FRα enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer.
    Chen L; Peng M; Li N; Song Q; Yao Y; Xu B; Liu H; Ruan P
    Sci Rep; 2018 Jan; 8(1):1188. PubMed ID: 29352248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.
    Onstenk W; Kraan J; Mostert B; Timmermans MM; Charehbili A; Smit VT; Kroep JR; Nortier JW; van de Ven S; Heijns JB; Kessels LW; van Laarhoven HW; Bos MM; van de Velde CJ; Gratama JW; Sieuwerts AM; Martens JW; Foekens JA; Sleijfer S
    Mol Cancer Ther; 2015 Mar; 14(3):821-7. PubMed ID: 25552367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective isolation of magnetic nanoparticle-mediated heterogeneity subpopulation of circulating tumor cells using magnetic gradient based microfluidic system.
    Kwak B; Lee J; Lee D; Lee K; Kwon O; Kang S; Kim Y
    Biosens Bioelectron; 2017 Feb; 88():153-158. PubMed ID: 27503409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients.
    Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K
    Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection and clinical value of epithelial cellular adhesion molecule (EpCAM) mRNA positive circulating tumor cells in metastatic breast cancer].
    Yan Y; Cheng JP; Di LJ; Song GH; Ren J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):275-80. PubMed ID: 22517003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-Aptamer-Targeted Immunomagnetic Nanoparticles to Accurately Explore the Correlations between Circulating Tumor Cells and Gastric Cancer.
    Li C; Yang S; Li R; Gong S; Huang M; Sun Y; Xiong G; Wu D; Ji M; Chen Y; Gao C; Yu Y
    ACS Appl Mater Interfaces; 2022 Feb; 14(6):7646-7658. PubMed ID: 35104098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.